Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Cardiology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Nephrology
    • Oncology
    • Rare Diseases
  • RESOURCES
  • CONTACT

Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations

  • Post author By salmocc
  • Post date July 21, 2026

Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations

 Oncology

Physicians:

American Academy of CME, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Practitioners and Nurses: 

American Academy of CME, Inc. designates this educational activity for 1.0 ANCC contact hours (0.7 pharmacotherapeutic contact hours).

Provider approved by the California Board of Registered Nursing.

California BRN Provider # CEP16993

Other HCPs:

Other members of the care team will receive a certificate of participation.

  • Listing ID: 3459

← From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension → Unmasking DKA: Updates on the Evolving Landscape of Diabetic Ketoacidosis